Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Study of SGR-1505 in Mature B-Cell Neoplasms

ClinicalTrials.gov ID: NCT05544019

Public ClinicalTrials.gov record NCT05544019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies

Study identification

NCT ID
NCT05544019
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Schrödinger, Inc.
Industry
Enrollment
98 participants

Conditions and interventions

Interventions

  • SGR-1505 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2023
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027
Last update posted
Feb 12, 2026

2023 – 2027

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Banner Health - MD Anderson Cancer Center Gilbert Arizona 85234 Recruiting
Christiana Care Hospital - Helen F Graham Cancer Center Newark Delaware 19713 Recruiting
Napa Research Pompano Beach Florida 99064 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Recruiting
Regional Cancer Care Associates Hackensack New Jersey 07601 Recruiting
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 Recruiting
Weill Cornell New York New York 10065 Recruiting
Montefiore Medical Center The Bronx New York 10467 Recruiting
Duke University Durham North Carolina 27710 Recruiting
Gabrail Cancer & Research Center Canton Ohio 44718 Recruiting
The Ohio State University - The James Cancer Hospital Columbus Ohio 43210 Recruiting
Oregon Health and Science University - Knight Cancer Institute Portland Oregon 97329 Recruiting
Rhode Island Hospital Providence Rhode Island 02903 Recruiting
University of Texas Southwestern Dallas Texas 75390 Recruiting
Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05544019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05544019 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →